Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report
Küçük Resim Yok
Tarih
2018
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Aves
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
This consensus report includes expert opinions and recommendations regarding the screening, and if necessary, the follow-up, prophylaxis, and treatment of hepatitis B before the treatment in patients who will undergo immunosuppressive therapy due to the risk of hepatitis B reactivation emergency. To increase awareness regarding the risk of hepatitis B reactivation in immunosuppressive patients, academicians from several university health research and training centers across Turkey came together and discussed the importance of the subject, current status, and issues in accordance with the current literature data and presented solutions.
Açıklama
Anahtar Kelimeler
Hepatitis B, Immunosuppressive Therapy, Reactivation Risk, Antiviral Prophylaxis, Stem-Cell Transplantation, Virus Hbv Reactivation, Cytotoxic Chemotherapy, Surface-Antigen, Cancer-Patients, Prevention, Management, Lymphoma, Identification, Prophylaxis
Kaynak
Turkish Journal Of Gastroenterology
WoS Q Değeri
Q4
Scopus Q Değeri
Q3
Cilt
29
Sayı
3
